Podcasts about clinical rheumatology

This week, Jonathan is joined by John ‘Jack' Cush, Director of Clinical Rheumatology at the Baylor Research Institute, Dallas, Texas, USA. The two doctors explore novel treatment avenues for rheumatic diseases, and discuss the exciting potential of AI and telemedicine.  Please use the following timestamps to navigate this episode:  (00:00)-Introduction   (02:29)-The history of beer and rock' n roll (06:10)-Transitioning into digital medical education (10:21)-Jack's podcast: RheumNow (14:30)-Challenges in lupus diagnosis and management (16:58)-IL-5 inhibitors: novel drugs for allergic vasculitis   (19:22)-How does diet affect inflammation and bone health? (24:22)-Telemedicine in rheumatology (29:26)-Lessons in rheumatoid arthritis care (33:30)-Soaring costs in healthcare (36:40)-New horizons in rheumatoid arthritis treatment (41:37)-The future of AI (43:30)-Jack's three wishes for rheumatology

Guest: Jason Busse, PhD Different clinical practice guidelines often have discrepancies from one another, making it a challenge for clinicians to determine which ones are more trustworthy. Here to break down the things clinicians should look for when sorting between guidelines that give discrepant recommendations is Dr. Jason Busse, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.

Guest: Jason Busse, PhD In light of the opioid epidemic, the use of cannabis for therapeutic purposes is becoming of interest. But since there are other alternatives that are often more effective and have better safety profiles, it's important to understand the evidence and guideline recommendations around these two treatment options. Here to share key considerations for using opioids and cannabis to treat patients living with chronic pain is Dr. Jason Busse, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.

Host: Michael Lewiecki, MD, FACP, FACE Although step therapy is the approach that many health plans and organizations are fond of, individualizing treatment decisions for patients with osteoporosis is essential, especially those who are at risk of fractures. To learn how you can create personalized treatment plans for patients with osteoporosis, tune in to hear Dr. Michael Lewiecki give us a recap of the session he presented at the 2024 Congress of Clinical Rheumatology.

Host: Michael Lewiecki, MD, FACP, FACE Here to talk about current concepts in the management of osteoporosis like insurance coverage, therapy sequencing, and comparative effectiveness is Dr. Michael Lewiecki, who presented a session on this exact topic at the 2024 Congress of Clinical Rheumatology.

In this episode, Dr Amy Prideaux interviews Professor Patrick Kiely about giant cell arteritis (GCA; a.k.a. temporal arteritis), covering diagnosis and management of this rheumatology emergency. Professor Patrick Kiely is a consultant rheumatologist and Professor of Practice in Clinical Rheumatology. -- Links -- British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis https://doi.org/10.1093/rheumatology/kez672 Trial of Tocilizumab in Giant-Cell Arteritis https://doi.org/10.1056/NEJMoa1613849 Tocilizumab for treating giant cell arteritis – NICE Technology appraisal guidance [TA518] https://www.nice.org.uk/guidance/ta518 Sound issues: We apologise for the audio disturbances in this episode. Recording date: 24 August 2022 -- Follow us -- https://www.instagram.com/rcpedintrainees https://twitter.com/RCPEdinTrainees -- Upcoming RCPE Events -- https://events.rcpe.ac.uk/ Feedback: cme@rcpe.ac.uk

How to Heal Fibromyalgia Naturally So many times patients with fibromyalgia are told that the only option they have to ease their pain is medication. While medication may seem like a great idea at the time, it can be extremely dangerous and could cause other complications down the road. In today's episode of The MaxLiving Podcast, Dr. Ryan & Ashley Berlin discuss what they believe is the best option to relieve fibromyalgia pain and help heal the body with corrective chiropractic care. Dr. Ryan explains a research study done by the Journal of Clinical Rheumatology (2022), which concluded that a misaligned neck (specifically the cervical curve) may be a key factor associated with fibromyalgia. For those who are unaware, a normal neck is supposed to be shaped like the letter “C”. Unfortunately though, physical, mental and emotional stress can cause the neck to change shape and become straight, creating dysfunction in the body. Luckily for patients with fibromyalgia, chiropractic care may be able to help regain the normal “C” shaped curve by removing interference in the spine and nervous system. Our MaxLiving doctors across North America have helped thousands of patients experience a life without limits. If you or someone you know has fibromyalgia, be sure to share this episode with them! For more of The MaxLiving Podcast, listen on Spotify, Apple Podcasts & more. *Please note: the information shared on this podcast are the opinions/views of the hosts. The contents of The MaxLiving Podcast and website are strictly for educational purposes and are not intended to be a replacement for professional medical advice, diagnosis, or treatment. Never ignore professional medical advice because of something you heard or read on The MaxLiving Podcast or website. If you have a medical emergency, call your doctor or 911 immediately. To find a doctor near you, visit maxliving.com/locations. For additional holistic health content, follow us on Instagram @maxlivingofficial and Facebook @maxliving.

In this episode, Avery H. LaChance, MD, MPH, speaks about clinical pearls in dermatomyositis and cutaneous lupus, including key cutaneous features of both diseases, work-up for patients with each disease, gold standard treatments, and novel therapeutics. Dr LaChance also spoke about these topics during a session at the Congress of Clinical Rheumatology in Destin, Florida on May 14, 2022.

In this episode, Michael R. McClung, MD, explains what is new in osteoporosis, including the evaluation and treatment of patients with osteoporosis, what the update of FRAX entails, and how it impacts clinical practice in rheumatology. Dr McClung presented on this topic at the Congress of Clinical Rheumatology in Destin, Florida on May 14, 2022.

In this episode, Arthur Kavanaugh, MD, explains what is new in psoriatic arthritis (PsA) in 2022, including new treatments, new treatment approaches, updates in the diagnosis PsA, and in safety considerations. Dr Kavanaugh presented this topic at the Congress of Clinical Rheumatology in Destin, Florida on May 11, 2022.

Marcela, Pedro e Fred discutem 7 armadilhas sobre a crise de gota. Pode usar alopurinol na crise? Precisa puncionar toda monoartrite? Colchicina, AINEs ou corticoide, qual é o melhor? Essas armadilhas e mais algumas são discutidas nesse episódio. Referências: Richette P, Doherty M, Pascual E, et al. 2016 updated EULAR evidence-based recommendations for the management of gout. Ann Rheum Dis 2016. Hill EM, et al. Does Starting Allopurinol Prolong Acute Treated Gout? A Randomized Clinical Trial. JCR - Journal of Clinical Rheumatology Apr 2015. Vol21 Issue 3. Taylor TH. Initiation of Allopurinol at First Medical Contact for Acute Attacks of Gout: A Randomized Clinical Trial. The American Journal of Medicine. Vol 125, Issue 11. Nov 2012.  Xin Feng, Yao Li, Wei Gao. Significance of the initiation time of urate-lowering therapy in gout patients: A retrospective research. Joint Bone Spine Volume 82, Issue 6, December 2015.  Park Y, Park Y, Lee S, et al. Clinical analysis of gouty patients with normouricaemia at diagnosisAnnals of the Rheumatic Diseases 2003;62:90-92.  LOGAN JA, MORRISON E, McGILL PE. Serum uric acid in acute goutAnnals of the Rheumatic Diseases 1997;56:696-697.  FitzGerald, J. D., Dalbeth, N., Mikuls, T., Brignardello‐Petersen, R., Guyatt, G., Abeles, A. M., ... & Neogi, T. (2020). 2020 American College of Rheumatology guideline for the management of gout. Arthritis care & research, 72(6), 744-760. Ragab, Gaafar, Mohsen Elshahaly, and Thomas Bardin. "Gout: An old disease in new perspective–A review." Journal of advanced research 8.5 (2017): 495-511. Janssens, H. J., Janssen, M., Van de Lisdonk, E. H., van Riel, P. L., & van Weel, C. (2008). Use of oral prednisolone or naproxen for the treatment of gout arthritis: a double-blind, randomised equivalence trial. The Lancet, 371(9627), 1854-1860. Parperis, K. (2021). Open-label randomised pragmatic trial (CONTACT) comparing naproxen and low-dose colchicine for the treatment of gout flares in primary care. Annals of the Rheumatic Diseases, 80(12), e202-e202. Barthélémy, I., Karanas, Y., Sannajust, J. P., Emering, C., & Mondié, J. M. (2001). Gout of the temporomandibular joint: pitfalls in diagnosis. Journal of Cranio-Maxillofacial Surgery, 29(5), 307-310. Terkeltaub, R. A., Furst, D. E., Bennett, K., Kook, K. A., Crockett, R. S., & Davis, M. W. (2010). High versus low dosing of oral colchicine for early acute gout flare: twenty‐four–hour outcome of the first multicenter, randomized, double‐blind, placebo‐controlled, parallel‐group, dose‐comparison colchicine study. Arthritis & Rheumatism, 62(4), 1060-1068. Lumezanu, E., Konatalapalli, R., & Weinstein, A. (2012). Axial (spinal) gout. Current rheumatology reports, 14(2), 161-164. Kienhorst, Laura BE, et al. "The validation of a diagnostic rule for gout without joint fluid analysis: a prospective study." Rheumatology 54.4 (2015): 609-614. Clebak, Karl T., Ashley Morrison, and Jason R. Croad. "Gout: Rapid evidence review." American family physician 102.9 (2020): 533-538. Robin, F., et al. "External validation of Gout-calculator performance on a cohort of acute arthritis (SYNOLACTATE) sparing distal joints such as hallux and midfoot. A cross-sectional study of 170 patients." Clinical Rheumatology 40.5 (2021): 1983-1988. Ma, Lingling, Ann Cranney, and Jayna M. Holroyd-Leduc. "Acute monoarthritis: what is the cause of my patient's painful swollen joint?." Cmaj 180.1 (2009): 59-65. Yu, K. H., et al. "Concomitant septic and gouty arthritis—an analysis of 30 cases." Rheumatology 42.9 (2003): 1062-1066. NBR 6023Janssens, Hein JEM, et al. "A diagnostic rule for acute gouty arthritis in primary care without joint fluid analysis.Archives of Internal Medicine170.13 (2010): 1120-1126

Pesquisadores Fisioterapeutas Joaquim Branco e Loiane Souza falando sobre publicação recente do Laboratório de Psicologia do Esporte e do Exercício (LAPE/CEFID/UDESC), sobre os efeitos do treinamento resistido sobre a saúde mental em pacientes com Fibromialgia. Fonte: Vilarino, G. T., Andreato, L. V., de Souza, L. C., Branco, J. H. L., & Andrade, A. (2021). Effects of resistance training on the mental health of patients with fibromyalgia: a systematic review. Clinical Rheumatology, 1-9. --- Support this podcast: https://anchor.fm/fabio-dominski/support

This episode details how psoriatic arthritis and the spondyloarthropathies came to be recognized as a distinct clinical entity after decades of nerdy arguing. Intro :10 Shout out to Cleveland Clinic Biologic Therapies Summit :30 In this episode 1:29 A 30,000-foot view 2:34 When did PsA separate from rheumatoid arthritis? 3:34 Mary Stults Sherman 7:11 Verna Wright and Dr. John Moll put PsA on the map 9:09 Recognizing PsA as a disease 15:20 An anecdote about Wright 16:18 Putting the SpA puzzle pieces together 18:19 The severity of disease 19:08 Episode wrap-up 20:46 Disclosures: Brown reports no relevant financial disclosures. We’d love to hear from you! Send your comments/questions to Dr. Brown at rheuminationspodcast@healio.com. Follow us on Twitter @HRheuminations @AdamJBrownMD @HealioRheum References: Ankylosing Spondylitis, Churchill Livingstone, Edinburgh, London, Melbourne, New York, 1980. Espinoza LR, Helliwell P. Clinical Rheumatology. 2014;33:1335-1336. Gladman DD, et al. Q J Med. 1987;62:127-141. Kane D, et al. Rheumatology. 2003;42:1460-1468. Moll JMH. Reumatismo. 2007;59 Suppl 1:13-18. Moll JM, Wright V. Semin Arthritis Rheum. 1973;3:55-78. Seronegative polyarthritis, North-Holland Pub. Co., New York, Amsterdam, 1976. Wright V. Am J Med. 1959;27:454-462. Wright V. Ann Rheum Dis. 1956;15:348-356. Wright V. BMJ. 1994;309:1739-1740.

"Ayurveda is a deep awareness of your own existence and life itself" - Dr. Ram Manohar.  Ayurveda has been plagued by various interpretations and misconceptions over the last century and has been relegated to status of alternate medicine for the longest time now.  But what is the true essence of this ancient science and how is it relevant in our lives. Join me in conversation with Dr. Ram Manohar, who has dedicated his life to the study and research in the science of Ayurveda. Listen in to his fascinating experience of the Gurukul system! Dr. P. Ram Manohar is the Research Director of Amrita School of Ayurveda and has been contributing in the field of Ayurvedic research for the last 29 years. He has to his credit more than 100 research papers published in journals. The most notable of them is a research study to scientifically evaluate the efficacy of Ayurveda in rheumatoid arthritis which was conducted in collaboration with the University of Washington, Seattle, University of California, Los Angeles and AVP, Coimbatore. The outcomes of this study were published in the Annals of Rheumatic Diseases and Journal of Clinical Rheumatology and won the prestigious Excellence in Integrative Medicine Research Award from the European Society of Integrative Medicine. He received his BAMS degree from Bharathiyar University, Coimbatore, in 1991 and MD (Ay) degree from Rajiv Gandhi University of Health Sciences, Bengaluru, in 2001. Dr. Manohar has been honored with numerous awards in this space and is also on the scientific advisory committee of the National Institute of Ayurveda AYUSH ministry, Govt of India.

  New Courses at PainExam Ultrasound Series Regenerative Medicine   Dr. Rosenblum Discusses the uses and theory behind Low Dose Naltrexone for Chronic Pain and Inflammation. References Debasish Hota, MD, DM, Anand Srinivasan, MD, Pinaki Dutta, MD, DM, Anil Bhansali, MD, DM, Amitava Chakrabarti, MD, DM, Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy, Pain Medicine, Volume 17, Issue 4, April 2016, Pages 790–791, https://doi.org/10.1093/pm/pnv009 Younger et al: The Use of Low-Dose Naltrexone (LDN) as a Novel Anti-Inflammatory Treatment for Chronic Pain. Clinical Rheumatology (2014) 33:451-459 KTojan, VroomanB.  Low-Dose Naltrexone (LDN) review of Therapeutic Utilization. Med. Sci. 2018, 6,82 Subscribe to our mailing list * indicates required Email Address *      

  New Courses at PainExam Ultrasound Series Regenerative Medicine   Dr. Rosenblum Discusses the uses and theory behind Low Dose Naltrexone for Chronic Pain and Inflammation. References Debasish Hota, MD, DM, Anand Srinivasan, MD, Pinaki Dutta, MD, DM, Anil Bhansali, MD, DM, Amitava Chakrabarti, MD, DM, Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy, Pain Medicine, Volume 17, Issue 4, April 2016, Pages 790–791, https://doi.org/10.1093/pm/pnv009 Younger et al: The Use of Low-Dose Naltrexone (LDN) as a Novel Anti-Inflammatory Treatment for Chronic Pain. Clinical Rheumatology (2014) 33:451-459 KTojan, VroomanB.  Low-Dose Naltrexone (LDN) review of Therapeutic Utilization. Med. Sci. 2018, 6,82

New Courses at PainExam Ultrasound Series Regenerative Medicine   Dr. Rosenblum Discusses the uses and theory behind Low Dose Naltrexone for Chronic Pain and Inflammation. References Debasish Hota, MD, DM, Anand Srinivasan, MD, Pinaki Dutta, MD, DM, Anil Bhansali, MD, DM, Amitava Chakrabarti, MD, DM, Off-Label, Low-Dose Naltrexone for Refractory Painful Diabetic Neuropathy, Pain Medicine, Volume 17, Issue 4, April 2016, Pages 790–791, https://doi.org/10.1093/pm/pnv009 Younger et al: The Use of Low-Dose Naltrexone (LDN) as a Novel Anti-Inflammatory Treatment for Chronic Pain. Clinical Rheumatology (2014) 33:451-459 KTojan, VroomanB.  Low-Dose Naltrexone (LDN) review of Therapeutic Utilization. Med. Sci. 2018, 6,82   Subscribe to our mailing list * indicates required Email Address *      

Does running increase symptoms of knee osteoarthritis like many people commonly think? The osteoarthritis initiative says no, and #SRPreqs is here to discuss the details leading to this promising evidence! Check it out to help your patients keep a pep in their step!  Grace H. Lo et al Clinical Rheumatology (2018) ------------ SRP is brought to you by the generous support of the SRP Game Changers. If you want to Join SRP, Crush Mediocrity, Join the Monthly Meetups, & Get some free swag!...go to http://SeniorRehabProject.com/Join

Host: Madelaine A. Feldman, MD, FACR Join Dr. Maddie Feldman as she gains exclusive insights from rheumatologist Dr. Jerry Pounds, who attended a lecture given by lupus guru Dr. Michelle Petri at this year’s Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida.

Host: Madelaine A. Feldman, MD, FACR Coming to you from the Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida, Dr. Maddie Feldman investigates a new test that has the potential to help predict which rheumatoid arthritis patients will respond to anti-TNF therapies.

Host: Madelaine A. Feldman, MD, FACR Dr. Marissa Sansone from Jersey City Medical Center-Barnabas Health shares her case study addressing IgG4-related diseases, such as fibroinflammatory disorders, with Dr. Maddie Feldman at this year’s Congress of Clinical Rheumatology’s Annual Meeting.

Host: Madelaine A. Feldman, MD, FACR Catch up on the latest findings on fibromyalgia with Dr. James Lipstate, who shares the highlights from Dr. Jarred Younger’s lecture, Microglia, New Targets in the Treatment of Fibromyalgia,given at this year’s Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida.

Host: Madelaine A. Feldman, MD, FACR After attending Dr. Michelle Petri’s talk on nonrenal lupus at the Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida, Dr. James Lipstate shares this recognized leader’s exclusive insights with Dr. Maddie Feldman.

Host: Madelaine A. Feldman, MD, FACR Hear from leading rheumatologist Dr. Theresa Lawrence-Ford on why non-pharmacologic interventions like ensuring patients’ musculoskeletal health and nutritional profile play a critical role in managing their symptoms and maintaining their day-to-day functionality. Dr. Lawrence-Ford caught up with Dr. Maddie Feldman at this year’s Congress of Clinical Rheumatology’s Annual Meeting.

Host: Madelaine A. Feldman, MD, FACR Are you looking for a resource that will help educate, promote, and advocate your rheumatology practice and patients? Then join Dr. Maddie Feldman as she speaks with Andrea Zlatkus, President of the National Organization of Rheumatology Managers (NORM), on the meeting floor of the Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida.

Host: Madelaine A. Feldman, MD, FACR If you’re thinking about opting out of Medicare, then you don’t want to miss private practice rheumatologist Dr. Ellen McKnight sharing her unique perspective and tips with Dr. Maddie Feldman at this year’s Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida.

Host: Madelaine A. Feldman, MD, FACR Couldn’t make this year’s Congress of Clinical Rheumatology’s Annual Meeting? Not a problem. Tune in as Dr. Stephen Lindsey reflects on Dr. Michelle Petri’s “Updates in Lupus Nephritis” lecture, Dr. Jarred Younger’s talk on fibromyalgia, and Dr. Daniel Culver’s presentation on “What’s New in Sarcoid” with Dr. Maddie Feldman.

Host: Madelaine A. Feldman, MD, FACR After attending Dr. Femia’s “Challenging Cases from the Dermatology-Rheumatology Clinic” lecture at the Congress of Clinical Rheumatology’s Annual Meeting, Dr. Maddie Feldman breaks down the top three things to do when treating cutaneous dermatomyositis.

Host: Madelaine A. Feldman, MD, FACR From overcoming difficulties in managing the puffy hand syndrome of scleroderma to using a new treatment for Raynaud disease, Dr. Maddie Feldman shares three quick pearls she took away from Dr. Alisa Femia’s lecture at this year’s Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida.

Host: Madelaine A. Feldman, MD, FACR Did you know that Hospitalizations for gout surpassed hospitalizations for rheumatoid arthritis since 2004? Or that the risk of allopurinol hypersensitivity reaction increases with age? Learn this and more from Dr. Maddie Feldman’s recap of Dr. Hyon Choi’s lecture, “Evidence-Based Guidelines for Optimal Gout Management,” at this year’s Congress of Clinical Rheumatology’s Annual Meeting in Destin, Florida.

A new study was published earlier this month (July 2017) in the journal Clinical Rheumatology looking at serious adverse events after HPV vaccination. The title of the study is: Serious adverse events after HPV vaccination: a critical review of randomized trials and post-marketing case series.  This is an international peer-reviewed journal that has been around since 1945. It is the “Journal of the International League of Associations for Rheumatology,” and is the official journal of the Belgian Rheumatology Society. The study was conducted by doctors from the Rheumatology Department and the Immunology Department at the National Institute of Cardiology in Mexico City. The results of their study found: The lack of inert placebo in the vast majority of prelicensure HPV vaccine randomized studiesLarge randomized trials disclosed significantly more severe adverse events in the tested HPV vaccine cohortPooled safety analysis found more post-immunization symptoms in bivalent HPV vaccine vs. hepatitis A vaccinePost-marketing HPV vaccine adverse events case series describe similar cluster of symptoms than those reported in pre-clinical trialsThe European Medicines Agency report on HPV vaccine safety looked at specific diagnoses and not at symptoms clustersIn-depth analysis of some supportive post-marketing HPV vaccine safety studies discloses disquieting findings The study found the statistics regarding the new Gardasil 9 particularly troubling, as the statistics suggest that severe harm is suffered every 140 injections, and the number needed to vaccinate in order to see any perceived benefits to the vaccine is 1757. Full Article: https://goo.gl/ZJpu86 Join Sharry as she shares ground breaking information regarding Gardasil.  Sharry's Full Article On Gardasil: https://goo.gl/v53gZ3